In conclusion, the expression of critical biogenomic markers, including the ACE2, ANPEP, EGFR, and IGF2R genes, plays a significant role in the development of mild clinical presentations in pediatric COVID-19 cases. This evidence concerns the gene ANPEP and COVID-19.